Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc. Web Site
Back to Directory   


 
   Upcoming Webcasts Printer Friendly Version
SYMBOL EVENT TITLE LISTEN TRANSCRIPT/BRIEF DATE TIME(ET)
There are no events at this time.
Conference calls are held by management to provide information on a variety of subjects, such as their recent results, outlook, and breaking news. Individuals now have the opportunity to listen to the same calls that only investment professionals had access to in the past. Click on the "Listen" icon to hear the call.
   Webcasts
SYMBOL EVENT TITLE  WEBCAST TRANSCRIPT/BRIEF DATETIME (ET)
VNDA   Q1 2013 Vanda Pharmaceuticals Inc. Earnings Conference Call PDF Download ($) 9-May-13 10:00 AM
VNDA   Q4 2012 Vanda Pharmaceuticals Inc. Earnings Conference Call PDF Download ($) 12-Feb-13 10:00 AM
VNDA   Vanda Pharmaceuticals Inc Conference Call to Discuss Top-Line Results of Phase IIb/III Clinical Study (MAGELLAN) in Major Depressive Disorder PDF Download ($) 31-Jan-13 9:00 AM
VNDA   Vanda Announces Positive Results in the Second Phase III Study (RESET) of Tasimelteon for the Treatment of Non-24-Hour Disorder -Conference Call PDF Download ($) 23-Jan-13 9:00 AM
VNDA   Vanda Pharmaceuticals Inc. Announces Positive Phase III Results For Tasimelteon In The Treatment Of Non-24-Hour Disorder- Conference Call PDF Download ($) 18-Dec-12 9:00 AM
VNDA   Q3 2012 Vanda Pharmaceuticals Inc. Earnings Conference Call PDF Download ($) 7-Nov-12 10:00 AM
VNDA   Q2 2012 Vanda Pharmaceuticals Inc. Earnings Conference Call PDF Download ($) 2-Aug-12 10:00 AM
VNDA   Q1 2012 Vanda Pharmaceuticals Inc. Earnings Conference Call this event is unavailable PDF Download ($) 8-May-12 10:00 AM
VNDA   Q4 2011 Vanda Pharmaceuticals Inc. Earnings Conference Call this event is unavailable PDF Download ($) 14-Feb-12 10:00 AM
VNDA   Q3 2011 Vanda Pharmaceuticals Inc Earnings Conference Call this event is unavailable PDF Download ($) 4-Nov-11 10:00 AM
VNDA   Q2 2011 Vanda Pharmaceuticals Inc Earnings Conference Call this event is unavailable PDF Download ($) 4-Aug-11 10:00 AM
VNDA   Q1 2011 Vanda Pharmaceuticals Inc Earnings Conference Call this event is unavailable PDF Download ($) 5-May-11 10:00 AM
VNDA   Q4 2010 Vanda Pharmaceuticals Inc. Earnings Conference Call this event is unavailable PDF Download ($) 10-Feb-11 10:00 AM
VNDA   Q3 2010 Vanda Pharmaceuticals Inc. Earnings Conference Call this event is unavailable PDF Download ($) 3-Nov-10 10:00 AM
VNDA   Q2 2010 Vanda Pharmaceuticals Inc. Earnings Conference Call this event is unavailable PDF Download ($) 5-Aug-10 10:00 AM
VNDA   Q1 2010 Vanda Pharmaceuticals Inc. Earnings Conference Call this event is unavailable PDF Download ($) 4-May-10 9:30 AM
VNDA   Q4 2009 Vanda Pharmaceuticals, Inc. Earnings Conference Call this event is unavailable PDF Download ($) 16-Feb-10 9:30 AM
VNDA   Q3 2009 Vanda Pharmaceuticals, Inc. Earnings Conference Call this event is unavailable PDF Download ($) 2-Nov-09 10:00 AM
VNDA   Vanda Pharmaceuticals, Inc. Enters into an Exclusive License Agreement for the Commercialization and Development of Fanapt(TM) in the U.S. and Canada for the Treatment of Schizophrenia Conference Call this event is unavailable PDF Download ($) 13-Oct-09 8:30 AM
VNDA   Q2 2009 Vanda Pharmaceuticals, Inc. Earnings Conference Call this event is unavailable PDF Download ($) 10-Aug-09 10:00 AM
VNDA   FDA Approves Vanda Pharmaceuticals' Fanapt(TM) for the Treatment of Schizophrenia - Conference Call this event is unavailable PDF Download ($) 7-May-09 10:30 AM
VNDA   Q2 2008 Vanda Pharmaceuticals, Inc. Earnings Conference Call this event is unavailable PDF Download ($) 5-Aug-08 10:30 AM
VNDA   Vanda Pharmaceuticals, Inc. Announces Receipt of Not Approvable Letter From FDA for Iloperidone this event is unavailable PDF Download ($) 28-Jul-08 10:30 AM
VNDA   Vanda Pharmaceuticals, Inc. Conference Call to discuss Phase III Data that shows Tasimelteon (VEC-162) Significantly Improves Sleep in Patients with Chronic Insomnia this event is unavailable PDF Download ($) 26-Jun-08 10:00 AM
VNDA   Vanda Pharmaceuticals, Inc. Analyst Meeting this event is unavailable 6-May-08 6:30 PM
VNDA   Q1 2008 Vanda Pharmaceuticals, Inc. Earnings Conference Call this event is unavailable PDF Download ($) 1-May-08 10:30 AM
VNDA   Q4 2007 Vanda Pharmaceuticals, Inc. Earnings Conference Call this event is unavailable PDF Download ($) 14-Feb-08 10:30 AM
VNDA   Q3 2007 Vanda Pharmaceuticals, Inc. Earnings Conference Call this event is unavailable PDF Download ($) 8-Nov-07 10:30 AM
VNDA   Q2 2007 Vanda Pharmaceuticals, Inc. Earnings Conference Call this event is unavailable 2-Aug-07 10:30 AM
VNDA   Q1 2007 Vanda Pharmaceuticals, Inc. Earnings Conference Call this event is unavailable PDF Download ($) 1-May-07 10:30 AM
VNDA   Q4 2006 Vanda Pharmaceuticals, Inc. Earnings Conference Call this event is unavailable PDF Download ($) 7-Feb-07 10:30 AM
VNDA   Vanda Pharmaceuticals, Inc. Conference Call to Discuss the Results of the Phase III trial this event is unavailable PDF Download ($) 7-Dec-06 9:00 AM
VNDA   Vanda Pharmaceuticals, Inc. Conference Call to Discuss the Results of Phase III Trial this event is unavailable PDF Download ($) 15-Nov-06 9:00 AM
VNDA   Q3 2006 Vanda Pharmaceuticals, Inc. Earnings Conference Call this event is unavailable PDF Download ($) 2-Nov-06 10:30 AM
VNDA   Q2 2006 Vanda Pharmaceuticals, Inc. Earnings Conference Call this event is unavailable PDF Download ($) 3-Aug-06 10:30 AM
VNDA   Q1 2006 Vanda Pharmaceuticals, Inc. Earnings Conference Call this event is unavailable PDF Download ($) 18-May-06 10:30 AM
   Earnings Releases
SYMBOL PERIOD EVENT TITLE EPS ESTIMATE EPS ACTUAL PREV. YEAR ACTUAL DATE/TIME (ET)
VNDA   Q2 2013 Q2 2013 Vanda Pharmaceuticals Inc. Earnings Release -$ 0.22  n/a  -$ 0.28  29-Jul-13 - 8-Aug-13
VNDA   Q1 2013 Q1 2013 Vanda Pharmaceuticals Inc. Earnings Release -$ 0.25  -$ 0.15  -$ 0.28  9-May-13 BMO
VNDA   Q4 2012 Q4 2012 Vanda Pharmaceuticals Inc. Earnings Release -$ 0.22  -$ 0.23  -$ 0.20  12-Feb-13 BMO
VNDA   Q3 2012 Q3 2012 Vanda Pharmaceuticals Inc. Earnings Release -$ 0.22  -$ 0.19  -$ 0.11  7-Nov-12 BMO
VNDA   Q2 2012 Q2 2012 Vanda Pharmaceuticals Inc. Earnings Release -$ 0.27  -$ 0.28  -$ 0.05  2-Aug-12 BMO
VNDA   Q1 2012 Q1 2012 Vanda Pharmaceuticals Inc. Earnings Release -$ 0.16  -$ 0.28  $ 0.00  8-May-12 BMO
VNDA   Q4 2011 Q4 2011 Vanda Pharmaceuticals Inc Earnings Release -$ 0.19  -$ 0.20  $ 0.08  14-Feb-12 BMO
VNDA   Q3 2011 Q3 2011 Vanda Pharmaceuticals Inc Earnings Release -$ 0.08  -$ 0.11  $ 0.11  4-Nov-11 BMO
VNDA   Q2 2011 Q2 2011 Vanda Pharmaceuticals Inc Earnings Release -$ 0.05  -$ 0.05  $ 0.04  4-Aug-11 BMO
VNDA   Q1 2011 Q1 2011 Vanda Pharmaceuticals Inc. Earnings Release $ 0.00  $ 0.00  $ 0.02  5-May-11 BMO
VNDA   Q4 2010 Q4 2010 Vanda Pharmaceuticals Inc. Earnings Release -$ 0.02  $ 0.08  -$ 0.34  10-Feb-11 BMO
VNDA   Q3 2010 Q3 2010 Vanda Pharmaceuticals Inc. Earnings Release $ 0.03  $ 0.11  -$ 0.28  3-Nov-10 BMO
VNDA   Q2 2010 Q2 2010 Vanda Pharmaceuticals Inc. Earnings Release $ 0.09  $ 0.04  -$ 0.46  5-Aug-10 BMO
VNDA   Q1 2010 Q1 2010 Vanda Pharmaceuticals Inc. Earnings Release $ 0.09  $ 0.02  -$ 0.24  4-May-10 BMO
VNDA   Q4 2009 Q4 2009 Vanda Pharmaceuticals, Inc. Earnings Release -$ 0.16  -$ 0.34  -$ 0.28  16-Feb-10 BMO
VNDA   Q3 2009 Q3 2009 Vanda Pharmaceuticals, Inc. Earnings Release -$ 0.31  -$ 0.28  -$ 0.41  2-Nov-09 BMO
VNDA   Q2 2009 Q2 2009 Vanda Pharmaceuticals, Inc. Earnings Release -$ 0.41  -$ 0.46  -$ 0.51  10-Aug-09 BMO
VNDA   Q1 2009 Q1 2009 Vanda Pharmaceuticals, Inc. Earnings Release -$ 0.22  -$ 0.24  -$ 0.72  29-Apr-09 BMO
VNDA   Q4 2008 Q4 2008 Vanda Pharmaceuticals, Inc. Earnings Release -$ 0.36  -$ 0.28  -$ 0.78  11-Feb-09 BMO
VNDA   Q3 2008 Q3 2008 Vanda Pharmaceuticals, Inc. Earnings Release -$ 0.40  -$ 0.41  -$ 0.82  30-Oct-08 BMO
VNDA   Q2 2008 Q2 2008 Vanda Pharmaceuticals, Inc. Earnings Release -$ 0.63  -$ 0.51  -$ 0.60  5-Aug-08 BMO
VNDA   Q1 2008 Q1 2008 Vanda Pharmaceuticals, Inc. Earnings Release -$ 0.84  -$ 0.72  -$ 0.61  1-May-08 BMO
VNDA   Q4 2007 Q4 2007 Vanda Pharmaceuticals, Inc. Earnings Release -$ 0.79  -$ 0.78  -$ 0.54  14-Feb-08 BMO
VNDA   Q3 2007 Q3 2007 Vanda Pharmaceuticals, Inc. Earnings Release -$ 0.97  -$ 0.82  -$ 0.55  8-Nov-07 BMO
VNDA   Q2 2007 Q2 2007 Vanda Pharmaceuticals, Inc. Earnings Release -$ 0.81  -$ 0.60  -$ 1.11  2-Aug-07
VNDA   Q1 2007 Q1 2007 Vanda Pharmaceuticals, Inc. Earnings Release -$ 0.56  -$ 0.61  n/a  1-May-07 BMO
VNDA   Q4 2006 Q4 2006 Vanda Pharmaceuticals, Inc. Earnings Release -$ 0.64  -$ 0.54  n/a  7-Feb-07
VNDA   Q3 2006 Q3 2006 Vanda Pharmaceuticals, Inc. Earnings Release -$ 0.95  -$ 0.55  n/a  2-Nov-06 BMO
VNDA   Q2 2006 Q2 2006 Vanda Pharmaceuticals, Inc. Earnings Release -$ 0.83  -$ 1.11  n/a  3-Aug-06 BMO
VNDA   Q1 2006 Q1 2006 Vanda Pharmaceuticals, Inc. Earnings Release n/a  n/a  n/a  18-May-06 BMO
   Presentations
EVENT SPONSOR AND TITLE LISTEN DATE TIME (ET)
Vanda Pharmaceuticals Inc. at BioCentury Publications Future Leaders in the Biot... 5-Apr-13 2:30 PM
Vanda Pharmaceuticals Inc. at Cowen Health Care Conference 4-Mar-13 4:50 PM
Vanda Pharmaceuticals Inc. at Lazard Capital Markets Healthcare Conference 14-Nov-12 3:00 PM
Vanda Pharmaceuticals Inc. at BioCentury and Thomson Reuters NewsMakers in the B... this event is unavailable 7-Sep-12 2:00 PM
Vanda Pharmaceuticals Inc. at Stifel Nicolaus Healthcare Conference 5-Sep-12 4:25 PM
Vanda Pharmaceuticals Inc. at JMP Securities Healthcare Conference this event is unavailable 13-Jul-12 1:00 PM
Vanda Pharmaceuticals Inc. at APSS Sleep Meeting this event is unavailable 11-Jun-12 5:00 PM
Vanda Pharmaceuticals Inc. at Jefferies Global Healthcare Conference 4-Jun-12 12:30 PM
Vanda Pharmaceuticals Inc. at Cowen Group Health Care Conference this event is unavailable 5-Mar-12 N/A
Vanda Pharmaceuticals Inc. at Citi Global Health Care Conference this event is unavailable 29-Feb-12 2:00 PM
Vanda Pharmaceuticals Inc. at RBC Capital Markets Global Healthcare Conference this event is unavailable 28-Feb-12 2:35 PM
Vanda Pharmaceuticals Inc at UBS Global Life Sciences Conference this event is unavailable 20-Sep-11 12:30 PM
Vanda Pharmaceuticals Inc at Jefferies Fall Mid-Atlantic Corporate Access Day this event is unavailable 9-Sep-11 N/A
Vanda Pharmaceuticals Inc at Stifel, Nicolaus & Company Inc. Healthcare Conferen... this event is unavailable 8-Sep-11 4:25 PM
Vanda Pharmaceuticals Inc at Jefferies & Co. Global Healthcare Conference this event is unavailable 9-Jun-11 8:30 AM
Vanda Pharmaceuticals, Inc. at Cowen and Company Healthcare Conference this event is unavailable 9-Mar-10 3:45 PM
Vanda Pharmaceuticals, Inc. at FBR Capital Markets Annual Spring Investor Confer...
SPONSOR: FBR & Co
this event is unavailable 28-May-08 9:00 AM
Vanda Pharmaceuticals, Inc. at Bank of America Securities Health Care Conference...
SPONSOR: Bank of America Corp
this event is unavailable 13-May-08 8:20 PM
Vanda Pharmaceuticals, Inc. at JPMorgan Healthcare Conference
SPONSOR: JPMorgan Chase & Co
this event is unavailable 7-Jan-08 12:30 PM
Vanda Pharmaceuticals, Inc. at American Society of Human Genetics Annual Meeting...
SPONSOR: American Society of Human Genetics
this event is unavailable 25-Oct-07 7:30 PM
Vanda Pharmaceuticals, Inc. at Natexis Bleichroeder Hidden Gems Conference this event is unavailable 8-Oct-07 3:15 PM
Vanda Pharmaceuticals, Inc. at SLEEP 2007
SPONSOR: Associated Professional Sleep Societies, LLC
this event is unavailable 13-Jun-07 5:00 PM
Vanda Pharmaceuticals, Inc. at 2007 FBR Growth Conference
SPONSOR: FBR & Co
this event is unavailable 30-May-07 10:30 AM
Vanda Pharmaceuticals, Inc. at Morgan Stanley Global Healthcare Unplugged Confer... this event is unavailable 2-May-07 8:00 AM
Vanda Pharmaceuticals, Inc. at Thomas Weisel Partners Healthcare Conference
SPONSOR: Thomas Weisel Partners LLC
this event is unavailable 6-Sep-06 5:00 PM
Vanda Pharmaceuticals, Inc. at Bank of America Specialty Pharmaceuticals Confere... this event is unavailable 11-Aug-06 12:45 PM
 
   Initial Public Offering
Proposed Ticker: VNDA  Expected Pricing Date: 12-Apr-06
Exchange: NASDQ Offering Price: $10.00
Lead Underwriter: JP Morgan Total Shares: 5,750,000
Form Filed: Est. Offering Amount: $59,642,000
Filing Date: